Life Sciences Accelerator Building

Royal Liverpool and Broadgreen University Hospitals NHS Trust & Liverpool School of Tropical Medicine

Liverpool Life Sciences

Royal Liverpool and Broadgreen University Hospitals NHS Trust 
& Liverpool School of Tropical Medicine

Architect:  IBI Group

Main Contractor:  IHP (JV Vinci UK & Sir Robert McAlpine)

Project Value:  £25m

Open Date:  October 2017

The Life Sciences Accelerator is a new laboratory development that will enable innovative, much-needed research into antibiotic resistance, the building, co-locates the Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool School of Tropical Medicine (LSTM) and a raft of relevant SMEs with larger scale industrial collaboration through pre-existing product development partnerships.  This 70,000 square foot building will provide state-of-the-art laboratory space and offices.

Following collaboration on a previous major containment laboratory facility, CCTech were brought into the project by the main contractor to advise on two areas within the new building.

  • An Advisory Committee on Dangerous Pathogens (ACDP) Containment Level 3 (CL3) suite, comprising six CL3 Laboratories totalling 205m2, supported by two shared Preparation Lobbies and a dedicated Entrance Lobby.

  • An HSE licenced insectary facility totalling 452m2 and including seven insectaries with a total area of 115m2.  The suite consists of 14 environmentally controlled rooms.  These contain the largest tsetse fly colony in the UK and a wide range of different mosquito species; two category 3 insectaries; two insecticide testing laboratories and two free flying rooms for studies on insect behaviour.

Insects transmit approximately 17% of global infectious disease in humans.  Malaria alone kills over half a million children each year and the incidence of other mosquito borne diseases such as dengue and is increasing rapidly.

Today LSTM hosts the largest concentration of medical entomologists in the UK with a research profile that spans from functional genomics of disease vectors to clinical trials; implementation research and the development of tools for monitoring and evaluation of disease transmission. 

CCTech Provided:

Input from a review of the Functional Requirement Specification which was fed into the Design Specification produced by the specialist
sub-contractor appointed to construct both facilities.  This included a Design and Operational Review of the proposed fumigation methodology
for the CL3 laboratories and accounted for the current UK and EU biocidal product regulations, physical requirements for use of the principle
agents, formaldehyde and hydrogen peroxide together with the necessary control systems.

CCTech provided Technical Support and advice to the main contractor, specialist sub-contractor and client throughout the construction phase,
including a review of Validation documentation, Compliance Monitoring with statutory licencing and requirements and support to the main
contractor during meetings with the specialist sub-contractor and client.  This service continued post practical completion and handover of the
building to include additional work areas such as commissioning of microbiological safety cabinets and fume cupboards within the overall building.